Cancer: payments to doctors
Payments that named Cancer as the associated device or medical supply, reported under the Sunshine Act for program years 2019–2025.
Was your doctor paid by Bio-rad Laboratories, Inc.?
Bio-rad Laboratories, Inc. reported the most payments naming Cancer. Search your clinician to see whether they are among them — and what else they were paid for.
Finding a payment is not a finding of wrongdoing — most reported payments are a meal during a presentation. What matters is the kind, the size, and how it compares with their peers, which is what the profile shows.
- Total reported
- $162K
- Providers
- 0
- Transactions
- 286
- Average per transaction
- $567
The per-transaction average — $567 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. No payment naming this product was reported to an individual clinician. The Sunshine Act also covers payments to teaching hospitals as institutions — research funding, grants and device loans — and for this product that is all of it.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Bio-rad Laboratories, Inc. | $162,145 | 100.0% |
Other products from Bio-rad Laboratories, Inc.
The company that reported the most payments naming Cancer also reports against these.
- Liquichek$1,258,626
- Lyphochek$679,788
- Chemistry$438,071
- Antibody$408,368
- Digital PCR System & Accessories$253,759
- Immunoassay$215,544
- Immunoassays$113,927
- Blood Typing$93,744
- BioPlex 2200$70,144
- Diabetes$59,854